Serofit 25 mg (Tablet)
Medicine Details
Category | Details |
---|---|
Generic | Sertraline hydrochloride |
Company | Everest pharmaceuticals ltd |
Also available as |
Indications
- Major depressive disorder (MDD)
- Obsessive-compulsive disorder (OCD)
- Panic disorder (PD)
- Post-traumatic stress disorder (PTSD)
- Social anxiety disorder (SAD)
- Premenstrual dysphoric disorder (PMDD)
Pharmacology
Sertraline has potent and selective inhibitory action on CNS neuronal reuptake of 5-HT resulting in increased 5-HT concentrations at the synaptic clefts, leading to facilitation of its sustained activity at the postsynaptic receptor sites.
Dosage & Administration
- Adults:
- Major depressive disorder:
- Starting Dose: 50 mg
- Therapeutic Range: 50-200 mg
- Obsessive-compulsive disorder:
- Starting Dose: 50 mg
- Therapeutic Range: 50-200 mg
- Panic disorder, Post-traumatic stress disorder, Social anxiety disorder:
- Starting Dose: 25 mg
- Therapeutic Range: 50-200 mg
- Major depressive disorder:
- Pediatric Patients (ages 6-12 years old):
- Obsessive-compulsive disorder:
- Starting Dose: 25 mg
- Therapeutic Range: 50-200 mg
- Obsessive-compulsive disorder:
- Premenstrual dysphoric disorder (PMDD):
- Starting dosage: 50 mg/day
- Continuous: Patients not responding to a 50 mg dosage may benefit from dosage increases at 50 mg increments per menstrual cycle up to 150 mg per day.
- Intermittent: Patients not responding to a 50 mg dosage may benefit from increasing the dosage up to a maximum of 100 mg per day during the next menstrual cycle (and subsequent cycles).
Interaction
Potential effects of co-administration of drugs that are highly bound to plasma proteins- As Serofit is tightly bound to plasma protein, the administration of Serofit to a patient taking another drug which is tightly bound to protein, may cause a shift in plasma concentrations potentially resulting in an adverse effect.
Contraindications
- Sertraline is contraindicated in patients with a known hypersensitivity to Sertraline or any of the excipients of drug.
- In patients with moderate to severe hepatic impairment is not recommended.
Side Effects
- Upset stomach
- Diarrhoea
- Constipation
- Vomiting
- Dry mouth
- Loss of appetite
- Weight changes
- Drowsiness
- Dizziness
- Headache
- Pain
- Burning or tingling in the hands or feet
- Excitement
- Sore throat
Pregnancy & Lactation
The safety of Sertraline during human pregnancy has not been established. Sertraline is known to be excreted in breast milk.
Precautions & Warnings
- Liver problems, kidney diseases, seizures, heart problems, and any allergies: Precaution should be taken.
- Dizziness or drowsiness: Caution should be taken in activities requiring alertness such as driving or using machinery.
- Elderly: Caution is advised while using Serofit.
- Monoamine oxidase inhibitor: Do not take Serofit if you have taken monoamine oxidase inhibitor in the last five weeks.
- Suicidal thinking and change of behavior: Close monitoring of the patient after 2 to 3 weeks of use is required.
Therapeutic Class
SSRIs & related anti-depressant drugs
Storage Conditions
Do not store above 30°C. Keep out of the reach of children.